Base Year
Historical Year
Forecast Year
The global life science tools market size was valued at USD 120.12 billion in 2023, driven by the increased research and development activities about life science across the globe. The market size is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032 to achieve a value of USD 271.86 billion by 2032.
| Global Life Science Tools Market Report Summary | Description | Value |
| Base Year | USD Billion | 2023 |
| Historical Period | USD Billion | 2018-2023 |
| Forecast Period | USD Billion | 2024-2032 |
| Market Size 2023 | USD Billion | 120.12 |
| Market Size 2032 | USD Billion | 271.86 |
| CAGR 2018-2023 | Percentage | XX% |
| CAGR 2024-2032 | Percentage | 9.5% |
| CAGR 2024-2032 - Market by Region | Asia Pacific | 12.3% |
| CAGR 2024-2032 - Market by Country | India | 14.1% |
| CAGR 2024-2032 - Market by Country | China | 11.8% |
| CAGR 2024-2032 - Market by Technology | Genomic Technology | 10.8% |
| CAGR 2024-2032 - Market by End Use | Biopharmaceutical Company | 10.7% |
| Market Share by Country 2023 | Japan | 4.6% |
Life sciences is the study of living organisms and life processes. Biotechnology is the most prominent component of the life sciences. It is a toolbox that leverages the basic understanding of natural sciences to create effective solutions for various world problems. Biotechnology is used to grow food to feed families and to make medicines and vaccines to fight diseases. Researchers and scientists are turning to biotechnology to find alternatives to fossil-based fuels for a cleaner, healthier planet.
The major life science tools include microscopy instruments, molecular analysis instruments, spectroscopy instruments, chromatography instruments and flow cytometry instruments. Other instruments include mass spectrometry instruments, biotechnology instruments, imaging systems, automated liquid handling systems, clinical diagnostics instruments, and laboratory automation systems, among others.
The growth of gene and cell therapies and their rising demand is anticipated to propel the market for life science tools. Various companies have started investing more funds and efforts on accelerating their research and development for efficient gene therapies. The therapies that can potentially address the cause of disease at the genetic level, further elevating the global life science tools market growth in response to the growing demand for effective disease treatment solutions.
Gene treatments are predicted to have a positive outlook in the coming years owing to an increase in the number of FDA-approved products. Furthermore, it is anticipated that improvements in recombinant DNA technology would increase the number of active clinical trials for gene therapy.
The market has significantly benefited from developments in targeted therapy due to a better understanding of how drugs interact with patients' genetic makeup. The life science segment is currently making use of cutting-edge developments like predictive analytics to improve the production of biological treatments to keep up with the market's rising demand further propelling the global life science tools market development.
Additionally, the FDA's clearance of monoclonal antibodies for use in cancer therapy and diagnostics is expanding the uses of biologics, which is projected to further enhance the market size. The growing synergy between academics and the life sciences sector is also fueling the market growth.
Market Breakup by Technology
Market Breakup by Product Type
Market Breakup by End User
Market Breakup by Region
| CAGR 2024-2032 - Market by | Country |
| India | 14.1% |
| China | 11.8% |
| Brazil | 10.4% |
| Canada | 9.0% |
| Australia | 8.4% |
| USA | 7.7% |
| UK | XX% |
| France | XX% |
| Japan | XX% |
| Saudi Arabia | XX% |
| Mexico | XX% |
| Germany | 7.0% |
| Italy | 5.9% |
The market for life science tools is expanding significantly as a result of ongoing developments made by the industry's leading manufacturers in the fields of sequencing, MS, chromatography, and NMR, among other goods. The rising investments made by governments and pharmaceutical corporations in the creation of cutting-edge therapies are also aiding the growth of the market. With the rising prevalence of diseases like cancer, renal and thyroid disorders, and diabetes, there is an increased desire for novel medicines and treatments, which is projected to add further value the global life science tools market share.
The rapid advancement of gene treatments and immunotherapies, which have shown promising results in curing diseases that were previously incurable, have been fuelling the growth of the market.
As pharmaceutical companies continue to invest more and more intensively in their development and allocate a larger portion of their research and development budget to biologics, biopharmaceuticals made from biological sources, such as living cells, will continue to gain prominence in the forecast period.
The growth of the market is also anticipated to be propelled by the increased collaboration between businesses, non-profit organisations, governments, and academic institutions in the development of innovative therapies and technologies.
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Technology |
|
| Breakup by Product Type |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The market attained a value of about USD 120.12 billion in 2023, driven by the increased research and development activities.
The market is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032, likely to reach a market value of USD 271.86 billion by 2032.
The factors which are contributing to the market growth include the rapidly developing healthcare sector and the increasing investments by governments and pharmaceutical corporations in the development of cutting-edge therapies, among others.
The development of targeted therapy due to a better understanding of how drugs interact with patients' genetic makeup is a major trend influencing the market growth.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.
Different life science tools present in the market are cell culture systems and 3d cell culture, liquid chromatography, mass spectrometry, flow cytometry, cloning and genome engineering, microscopy and electron microscopy, next generation sequencing, PCR and qPCR, nucleic acid preparation, nucleic acid microarray, sanger sequencing, transfection devices and gene delivery technologies, NMR, other separation technologies, products and services, among others.
The technologies used in life science tools are genomic technology, proteomics technology, cell biology technology, other analytical and sample preparation technology, lab supplies and technologies, among others.
The end users of life science tools are government and academic, biopharmaceutical company, healthcare, and industrial applications, among others.
Key players involved in the market are Agilent Technologies, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., Danaher Corporation, Illumina, Inc., Thermo Fisher Scientific, Inc., QIAGEN N.V., Merck KGaA, Shimadzu Corporation, Hitachi, Ltd., Bruker Corporation, Oxford Instruments plc, and Zeiss International.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124
Share